Summary

Coronary Artery Bypass Graft Market – Scope of Report
TMR’s report on the global coronary artery bypass graft market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global coronary artery bypass graft market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global coronary artery bypass graft market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the coronary artery bypass graft market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global coronary artery bypass graft market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global coronary artery bypass graft market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global coronary artery bypass graft market.

The report delves into the competitive landscape of the global coronary artery bypass graft market. Key players operating in the global coronary artery bypass graft market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global coronary artery bypass graft market profiled in this report.

Key Questions Answered in Global coronary artery bypass graft Market Report
• What is the sales/revenue generated by coronary artery bypass graft across all regions during the forecast period?
• What are the opportunities in the global coronary artery bypass graft market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Coronary Artery Bypass Graft Market – Research Objectives and Research Approach
The comprehensive report on the global coronary artery bypass graft market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global coronary artery bypass graft market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global coronary artery bypass graft market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coronary Artery Bypass Graft Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Coronary Artery Bypass Graft Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. On-pump CABG
6.3.2. Off-pump CABG
6.3.3. Minimally Invasive Direct CABG
6.3.4. Conventional CABG
6.4. Market Attractiveness, by Product Type
7. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Device
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Device, 2017–2031
7.3.1. Tissue Stabilizers
7.3.2. Heart Positioners
7.3.3. Refractors
7.3.4. Cannulas
7.3.5. Cardiopulmonary Bypass Machines
7.3.6. Endoscopic Vessel Harvesting Systems
7.3.7. Others
7.3.8. 7.4 Market Attractiveness, by Device
8. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Technique
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technique, 2017–2031
8.3.1. Traditional Vessel Harvesting
8.3.2. Endoscopic Vessel Harvesting (EVH)
8.4. Market Attractiveness, by Technique
9. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Cardiology Clinics
9.3.3. Research & Academic Institutions
9.4. Market Attractiveness, by End-user
10. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Coronary Artery Bypass Graft Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. On-pump CABG
11.2.2. Off-pump CABG
11.2.3. Minimally Invasive Direct CABG
11.2.4. Conventional CABG
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Device, 2017–2031
11.4.1. Tissue Stabilizers
11.4.2. Heart Positioners
11.4.3. Refractors
11.4.4. Cannulas
11.4.5. Cardiopulmonary Bypass Machines
11.4.6. Endoscopic Vessel Harvesting Systems
11.4.7. Others
11.5. Market Attractiveness, by Device
11.6. Market Value Forecast, by Technique, 2017–2031
11.6.1. Traditional Vessel Harvesting
11.6.2. Endoscopic Vessel Harvesting (EVH)
11.7. Market Attractiveness, by Technique
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Cardiology Clinics
11.8.3. Research & Academic Institutions
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Device
11.11.3. By Technique
11.11.4. By End-user
11.11.5. By Country
12. Europe Coronary Artery Bypass Graft Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. On-pump CABG
12.2.2. Off-pump CABG
12.2.3. Minimally Invasive Direct CABG
12.2.4. Conventional CABG
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Device, 2017–2031
12.4.1. Tissue Stabilizers
12.4.2. Heart Positioners
12.4.3. Refractors
12.4.4. Cannulas
12.4.5. Cardiopulmonary Bypass Machines
12.4.6. Endoscopic Vessel Harvesting Systems
12.4.7. Others
12.5. Market Attractiveness, by Device
12.6. Market Value Forecast, by Technique, 2017–2031
12.6.1. Traditional Vessel Harvesting
12.6.2. Endoscopic Vessel Harvesting (EVH)
12.7. Market Attractiveness, by Technique
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Cardiology Clinics
12.8.3. Research & Academic Institutions
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Device
12.11.3. By Technique
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Coronary Artery Bypass Graft Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. On-pump CABG
13.2.2. Off-pump CABG
13.2.3. Minimally Invasive Direct CABG
13.2.4. Conventional CABG
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Device, 2017–2031
13.4.1. Tissue Stabilizers
13.4.2. Heart Positioners
13.4.3. Refractors
13.4.4. Cannulas
13.4.5. Cardiopulmonary Bypass Machines
13.4.6. Endoscopic Vessel Harvesting Systems
13.4.7. Others
13.5. Market Attractiveness, by Device
13.6. Market Value Forecast, by Technique, 2017–2031
13.6.1. Traditional Vessel Harvesting
13.6.2. Endoscopic Vessel Harvesting (EVH)
13.7. Market Attractiveness, by Technique
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Cardiology Clinics
13.8.3. Research & Academic Institutions
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Device
13.11.3. By Technique
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Coronary Artery Bypass Graft Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. On-pump CABG
14.2.2. Off-pump CABG
14.2.3. Minimally Invasive Direct CABG
14.2.4. Conventional CABG
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Device, 2017–2031
14.4.1. Tissue Stabilizers
14.4.2. Heart Positioners
14.4.3. Refractors
14.4.4. Cannulas
14.4.5. Cardiopulmonary Bypass Machines
14.4.6. Endoscopic Vessel Harvesting Systems
14.4.7. Others
14.5. Market Attractiveness, by Device
14.6. Market Value Forecast, by Technique, 2017–2031
14.6.1. Traditional Vessel Harvesting
14.6.2. Endoscopic Vessel Harvesting (EVH)
14.7. Market Attractiveness, by Technique
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Cardiology Clinics
14.8.3. Research & Academic Institutions
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Device
14.11.3. By Technique
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Coronary Artery Bypass Graft Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. On-pump CABG
15.2.2. Off-pump CABG
15.2.3. Minimally Invasive Direct CABG
15.2.4. Conventional CABG
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Device, 2017–2031
15.4.1. Tissue Stabilizers
15.4.2. Heart Positioners
15.4.3. Refractors
15.4.4. Cannulas
15.4.5. Cardiopulmonary Bypass Machines
15.4.6. Endoscopic Vessel Harvesting Systems
15.4.7. Others
15.5. Market Attractiveness, by Device
15.6. Market Value Forecast, by Technique, 2017–2031
15.6.1. Traditional Vessel Harvesting
15.6.2. Endoscopic Vessel Harvesting (EVH)
15.7. Market Attractiveness, by Technique
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Cardiology Clinics
15.8.3. Research & Academic Institutions
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Device
15.11.3. By Technique
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Medtronic Plc
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. TERUMO CORPORATION
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. KARL STORZ GmbH & Co. KG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sorin Group (LivaNova PLC)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Boston Scientific
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Ethicon US, LLC (Johnson & Johnson)
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. NeoGraft Technologies, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Edwards Lifesciences Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. MAQUET Holding B.V. & Co. KG
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Genesee Biomedical Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview